Wedge Capital Management L LP Has Cut Signature Bank (SBNY) Holding By $19.93 Million; Wilbanks Smith & Thomas Asset Management Increased Its Johnson & Johnson (JNJ) Holding

June 22, 2018 - By Nellie Frank

Johnson & Johnson (NYSE:JNJ) Logo

Wedge Capital Management L LP decreased Signature Bank (SBNY) stake by 17.74% reported in 2018Q1 SEC filing. Wedge Capital Management L LP sold 141,342 shares as Signature Bank (SBNY)’s stock declined 15.57%. The Wedge Capital Management L LP holds 655,501 shares with $93.05 million value, down from 796,843 last quarter. Signature Bank now has $7.08 billion valuation. The stock decreased 0.09% or $0.12 during the last trading session, reaching $131.86. About 73,776 shares traded. Signature Bank (NASDAQ:SBNY) has declined 9.96% since June 22, 2017 and is downtrending. It has underperformed by 22.53% the S&P500. Some Historical SBNY News: 19/04/2018 – Signature Bank 1Q Net $34.58M; 22/03/2018 – SIGNATURE BANK SBNY.O : UBS STARTS WITH NEUTRAL RATING: TARGET PRICE $163; 22/03/2018 – Signature Bank Closes Below 50-Day Moving Average: Technicals; 17/04/2018 – SIGNATURE BANK APPOINTS VETERAN BANKERS TO HEAD WEST COAST OPERATIONS; FLAGSHIP OFFICE TO OPEN IN SAN FRANCISCO; 23/04/2018 – Research Report Identifies Signature Bank, Concert Pharmaceuticals, Easterly Government Properties, Hilltop, Columbia Banking S; 21/04/2018 – DJ Signature Bank, Inst Holders, 1Q 2018 (SBNY); 19/04/2018 – Signature Bank 1Q EPS 63c; 24/04/2018 – Signature Bank Expands Network with Appointment of Two Private Client Banking Teams; 19/04/2018 – Signature Bank 1Q Adj EPS $2.69; 16/03/2018 Signature Bank Announces Availability of Materials for 2018 Annual Shareholders’ Meeting

Wilbanks Smith & Thomas Asset Management Llc increased Johnson & Johnson (JNJ) stake by 22.01% reported in 2018Q1 SEC filing. Wilbanks Smith & Thomas Asset Management Llc acquired 16,925 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Wilbanks Smith & Thomas Asset Management Llc holds 93,817 shares with $12.02 million value, up from 76,892 last quarter. Johnson & Johnson now has $329.48 billion valuation. The stock increased 1.14% or $1.39 during the last trading session, reaching $122.84. About 1.13 million shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 22, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 08/05/2018 – J&J’s Janssen: Darzalex Is the First Monoclonal Antibody Approved for Newly Diagnosed Patients With Newly Diagnosed Multiple Myeloma; 18/04/2018 – KENTUCKY SUES JOHNSON & JOHNSON, ACCUSES COMPANY OF DEVISING DECEPTIVE OPIOID MARKETING SCHEME; 30/04/2018 – Football Rumors: Steelers Release S J.J. Wilcox; 17/04/2018 – J&J – QTRLY WORLDWIDE CONSUMER SALES $3,398 MLN VS $3,228 MLN REPORTED LAST YR; 14/05/2018 – STAT Plus: AbbVie and J&J reverse course on a price hike in face of criticism; 17/04/2018 – Johnson & Johnson Raises 2018 View To Sales $81B-$81.8B; 15/03/2018 – JNJ ERDAFITINIB DESIGNATION FOR METASTATIC UROTHELIAL CANCER; 17/04/2018 – J&J – EXPECTS TO RECORD PRE-TAX RESTRUCTURING CHARGES OF APPROXIMATELY $1.9 TO $2.3 BLN, WHICH WILL BE TREATED AS A SPECIAL ITEM; 03/05/2018 – J&J Presenting at UBS Conference May 21; 17/04/2018 – Johnson & Johnson Raises Sales Outlook

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Wednesday, April 20 by Goldman Sachs. The rating was maintained by Jefferies on Tuesday, August 15 with “Hold”. The firm has “Neutral” rating given on Monday, March 14 by Goldman Sachs. The firm has “Hold” rating given on Tuesday, September 13 by Jefferies. The firm has “Equal-Weight” rating given on Tuesday, November 29 by Barclays Capital. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, October 18 report. The rating was maintained by Credit Suisse with “Buy” on Thursday, October 19. The firm earned “Sell” rating on Tuesday, January 23 by BTIG Research. Jefferies maintained the stock with “Hold” rating in Thursday, July 14 report. The rating was maintained by Jefferies on Tuesday, March 15 with “Hold”.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson: Strong Company, But Won’t Fit In Most Portfolios” on June 21, 2018, also Forbes.com with their article: “What Are Johnson & Johnson’s Key Sources Of Revenue?” published on June 20, 2018, Fool.com published: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” on June 20, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” published on June 01, 2018 as well as Fool.com‘s news article titled: “Better Buy: Pfizer Inc. vs. Johnson & Johnson” with publication date: June 17, 2018.

Investors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Cardinal Cap Incorporated reported 121,829 shares. Papp L Roy Associates accumulated 92,909 shares or 2.28% of the stock. Shapiro Cap Lc stated it has 4,292 shares. Cohen Cap invested 1.71% of its portfolio in Johnson & Johnson (NYSE:JNJ). Willow Creek Wealth Mgmt Inc holds 12,653 shares or 0.87% of its portfolio. Ftb Inc reported 61,065 shares. Windsor Management Ltd Liability Corporation invested in 0.53% or 8,768 shares. Janney Capital Mngmt Limited Liability Corp holds 1.54% or 275,954 shares in its portfolio. Strategy Asset Managers holds 2.46% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 88,437 shares. Keating Inv Counselors Incorporated holds 68,585 shares. Winslow Evans & Crocker has invested 0% in Johnson & Johnson (NYSE:JNJ). Berkshire Asset Management Lc Pa holds 2.75% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 221,307 shares. Stone Ridge Asset Ltd Liability Company stated it has 102,877 shares. Rockland Tru owns 153,349 shares for 2.6% of their portfolio. Lathrop Invest Mgmt Corporation stated it has 0.1% in Johnson & Johnson (NYSE:JNJ).

Since February 15, 2018, it had 0 insider buys, and 1 insider sale for $20.17 million activity. 155,342 shares were sold by Stoffels Paulus, worth $20.17M on Thursday, February 15.

Wilbanks Smith & Thomas Asset Management Llc decreased Sanofi Aventis (NYSE:SNY) stake by 41,121 shares to 33,346 valued at $1.34M in 2018Q1. It also reduced Ishares Msci Acwi Min Vol (ACWV) stake by 5,620 shares and now owns 5,530 shares. General Electric (NYSE:GE) was reduced too.

Among 24 analysts covering Signature Bank (NASDAQ:SBNY), 18 have Buy rating, 0 Sell and 6 Hold. Therefore 75% are positive. Signature Bank had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Outperform” rating by FBR Capital given on Thursday, July 21. The firm has “Neutral” rating given on Tuesday, May 31 by Piper Jaffray. The stock of Signature Bank (NASDAQ:SBNY) earned “Hold” rating by Zacks on Thursday, August 27. Merion Capital Group reinitiated the stock with “Outperform” rating in Friday, April 1 report. The rating was maintained by Barclays Capital on Friday, October 9 with “Equal-Weight”. The stock of Signature Bank (NASDAQ:SBNY) has “Buy” rating given on Friday, January 19 by Maxim Group. As per Tuesday, January 9, the company rating was maintained by Wells Fargo. The stock of Signature Bank (NASDAQ:SBNY) earned “Underperform” rating by Hovde Group on Friday, November 18. The firm earned “Buy” rating on Monday, December 18 by BMO Capital Markets. On Thursday, April 6 the stock rating was downgraded by Raymond James to “Outperform”.

Wedge Capital Management L LP increased H.B. Fuller Company (NYSE:FUL) stake by 98,649 shares to 641,989 valued at $31.93M in 2018Q1. It also upped B&G Foods Inc. (NYSE:BGS) stake by 195,504 shares and now owns 1.03 million shares. Unitedhealth Group Incorporated (NYSE:UNH) was raised too.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: